Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Operating Leases (2019 - 2025)

Historic Operating Leases for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 9 years, with Q1 2025 value amounting to $5.4 million.

  • Lifecore Biomedical, Inc. \De\'s Operating Leases rose 617.14% to $5.4 million in Q1 2025 from the same period last year, while for Feb 2025 it was $5.4 million, marking a year-over-year increase of 617.14%. This contributed to the annual value of $1.7 million for FY2024, which is 8219.18% down from last year.
  • As of Q1 2025, Lifecore Biomedical, Inc. \De\'s Operating Leases stood at $5.4 million, which was up 617.14% from $7.4 million recorded in Q4 2024.
  • In the past 5 years, Lifecore Biomedical, Inc. \De\'s Operating Leases ranged from a high of $17.9 million in Q1 2021 and a low of $1.7 million during Q2 2024
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s median Operating Leases value was $7.8 million (recorded in 2022), while the average stood at $8.9 million.
  • Per our database at Business Quant, Lifecore Biomedical, Inc. \De\'s Operating Leases surged by 3296.3% in 2023 and then tumbled by 8219.18% in 2024.
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s Operating Leases (Quarter) stood at $11.3 million in 2021, then tumbled by 38.12% to $7.0 million in 2022, then skyrocketed by 32.96% to $9.3 million in 2023, then dropped by 20.47% to $7.4 million in 2024, then decreased by 27.23% to $5.4 million in 2025.
  • Its Operating Leases stands at $5.4 million for Q1 2025, versus $7.4 million for Q4 2024 and $4.8 million for Q3 2024.